ClinicalTrials.gov
public full text
Public Domain
A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19
This study is designed as a multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the clinical efficacy and safety of MW33 injection in patients with mild or moderate COVID-19, and to evaluate its pharmacokinetic profile and immunogenicity.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- ACTIV-2: A Study for Outpatients With COVID-19#311166
- Photodynamic Therapy for the Treatment of COVID-19#1057140
- Adaptive COVID-19 Treatment Trial 3 (ACTT-3)#125924
- Replication data for: Differential COVID-19 Vaccine Antibody Responses Across Immunosuppressive Medications: A Prospective Cohort Study#411701
- Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)#148582
Record · ID 1127428
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive